Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 24,539 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,525 | N/A | N/A | N/A | N/A |
| Gross Profit | 23,014 | N/A | N/A | N/A | N/A |
| Operating Expenses | 120,194 | 70,989 | 47,301 | 16,736 | 5,683 |
| Operating Income | -96,655 | -70,989 | -47,301 | -16,736 | -5,683 |
| Interest Expense | 3,734 | 0 | 0 | 0 | 0 |
| Other Income | -270 | 469 | 1,590 | 233 | -918 |
| Pre-tax Income | -100,659 | -70,520 | -45,711 | -16,503 | -6,601 |
| Net Income Continuous | -100,659 | -70,520 | -45,711 | -16,503 | -6,601 |
| Net Income | $-100,659 | $-70,520 | $-45,711 | $-16,503 | $-6,601 |
| EPS Basic Total Ops | -3.87 | -2.92 | -9.97 | -11.69 | -13.56 |
| EPS Basic Continuous Ops | -3.87 | -2.92 | -9.97 | -11.69 | -4.67 |
| EPS Diluted Total Ops | -3.87 | -2.92 | -9.97 | -11.69 | -13.56 |
| EPS Diluted Continuous Ops | -3.87 | -2.92 | -9.97 | -11.69 | -4.67 |
| EPS Diluted Before Non-Recurring Items | -3.87 | -2.92 | -9.97 | N/A | N/A |
| EBITDA(a) | $-95,130 | $-70,912 | $-47,282 | $-16,736 | $-5,683 |